R. Verge

发表

Preparation and characterization of bupivacaine-loaded polylactide and polylactide-co-glycolide microspheres

P. Corre, F. Chevanne, P. L. Guevello, 1994 .

Cerebrospinal fluid and plasma disposition of yohimbine and 11-hydroxy-yohimbine in young and older healthy subjects, and Alzheimer's disease patients

E. Peskind, M. Raskind, P. Corre, 1997, European Journal of Clinical Pharmacology.

Expression of altered α2‐adrenergic phenotypic traits in normotensive humans at genetic risk of hereditary (essential) hypertension

D. O'Connor, P. Insel, B. Kennedy, 1998, Journal of hypertension.

Non linear disposition of thiopentone following long-term infusion

P. Corre, Y. Mallédant, R. Verge, 1993, European Journal of Drug Metabolism and Pharmacokinetics.

Increase of doxorubicin penetration in cultured rat hepatocytes by its binding to polymethacrylic nanoparticles

A. Guillouzo, A. Rolland, R. Verge, 1989 .

Inclusion complexation of amide-typed local anaesthetics with β-cyclodextrin and its derivatives. I. Physicochemical characterization

P. Corre, F. Chevanne, R. Verge, 1996 .

Inclusion complexation of amide-typed local anaesthetics with β-cyclodextrin and its derivatives. II. Evaluation of affinity constants and in vitro transfer rate constants

P. Corre, F. Chevanne, R. Verge, 1996 .

Inclusion complexation of amide-typed local anesthetics with β-cyclodextrin and its derivatives. III. Biopharmaceutics of bupivacaine-SBE7-βCD complex following percutaneous sciatic nerve administration in rabbits

P. Corre, F. Chevanne, R. Verge, 1998 .

The pharmacokinetics and pharmacodynamics of bupivacaine-loaded microspheres on a brachial plexus block model in sheep.

P. Corre, C. Ecoffey, J. Estebe, 2001 .

Clinical Pharmacokinetics of Levorotatory and Racemic Disopyramide, at Steady State, Following Oral Administration in Patients with Ventricular Arrhythmias

J. Daubert, P. Sado, P. Corre, 1989, Journal of clinical pharmacology.

Sciatic nerve block with bupivacaine-loaded microspheres prevents hyperalgesia in an inflammatory animal model

J. Moulinoux, P. Corre, C. Ecoffey, 2002, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

α2‐Adrenoceptor antagonist potencies of two hydroxylated metabolites of yohimbine

M. Berlan, J. Galitzky, P. Corre, 1993, British journal of pharmacology.

In vitro and in vivo evaluation of polylactide and polylactide-co-glycolide microspheres of morphine for site-specific delivery

P. Corre, F. Chevanne, E. Polard, 1996 .

Effect of dexamethasone on motor brachial plexus block with bupivacaine and with bupivacaine-loaded microspheres in a sheep model

R. Le Verge, P. Corre, C. Ecoffey, 2003, European journal of anaesthesiology.

Effects of Alzheimer's disease and normal aging on cerebrospinal fluid norepinephrine responses to yohimbine and clonidine.

E. Peskind, M. Raskind, D. Dobie, 1995, Archives of general psychiatry.

In vitro controlled release kinetics of local anaesthetics from poly(D,L-lactide) and poly(lactide-co-glycolide) microspheres.

R. Le Verge, P. Corre, J. H. Rytting, 1997, Journal of microencapsulation.

Ex vivo and in situ PLGA microspheres uptake by pig ileal Peyer's patch segment.

E. Albina, R. Le Verge, P. Corre, 2000, International journal of pharmaceutics.

Biopharmaceutics and metabolism of yohimbine in humans.

R. Le Verge, P. Corre, F. Chevanne, 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

In vitro and in vivo microdialysis calibration using retrodialysis for the study of the cerebrospinal distribution of bupivacaine.

R. Le Verge, P. Corre, J. Malinovsky, 1998, Journal of pharmaceutical and biomedical analysis.

Spinal controlled delivery of bupivacaine from DL-lactic acid oligomer microspheres.

R. Le Verge, J. Estebe, Y. Mallédant, 1995, Journal of pharmaceutical sciences.